SCL Lifesciences Limited - pharma in Punjab, India. FY 2026 financials & compliance.
CIN U24112PB1993PLC014017 Incorporated 20 December 1993 ROC Chandigarh HQ Punjab, India
Active Public Limited Company pharma MSME · Medium
Revenue · FY 2026
₹305.27 Cr
▼ 10% YoY
Net profit · FY 2026
₹58.4 Cr
Net margin 19.1%
EBITDA · FY 2026
₹86.63 Cr
EBITDA margin 28.4%
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹5 Cr
Issued & subscribed
Open charges
₹30.75 Cr
Satisfied ₹109.32 Cr
Company age
33 yrs
Est. 1993
Employees · EPFO
862
Provident fund records

About SCL Lifesciences Limited

Data last updated:

SCL Lifesciences Limited is a public limited company based in Punjab, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 20 December 1993 and has been in existence for over 33 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24112PB1993PLC014017. Its GSTIN is 03AACCS4745B1ZU (Punjab). The company holds 15 GST registrations, of which 5 are active.

The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹5 Cr. It was formerly known as Saurav Chemicals Private Limited. It is led by directors including Parveen Goyal (Managing Director) and Udayan Sengupta (Whole-Time Director).

Its last annual general meeting (AGM) was held on 15 June 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Vill Saidpuradera Bassi Barwala Road Dera Bassi, Punjab, India.

As per the financials filed for FY 2026, the company reported a revenue of ₹305.27 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹58.4 Cr (net margin 19.1%) and EBITDA of ₹86.63 Cr (EBITDA margin 28.4%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 1% over five years.

The company has about 862 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: SCL Lifesciences. As per MCA filings, the company has open charges of ₹30.75 Cr and satisfied charges of ₹109.32 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 1 case is pending. The company has 14 deals on record (10 secondary share transfers, 2 rights issues, 2 funding rounds), with disclosed funding of ₹15.2 Cr; the latest was in April 2024. Its 6 peer companies in the Pharma industry (API Manufacturers, Lifesciences), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations) are compared by revenue, 3 larger and 3 smaller; the largest is R.L.Fine Chem Private Limited with revenue of ₹360.48 Cr. The company has 21 MSME Form 1 returns on record between 2019 and 2024, listing 61 overdue payments to 37 micro and small suppliers.

SCL Lifesciences Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0000327). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sauravchemicals.com.

Company details

CIN U24112PB1993PLC014017
Registration Number 014017
Incorporation Date 20 December 1993
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HR-13-0000327

CIN history

SCL Lifesciences has one previous CIN (Corporate Identification Number): L24112PB1993PLC014017. The current CIN is U24112PB1993PLC014017, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24112PB1993PLC014017Current
L24112PB1993PLC014017Previous

Recognitions & Rankings of SCL Lifesciences

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-HR-13-0000327

Contact details

SCL Lifesciences Limited's registered office is in Punjab. Its website is sauravchemicals.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Vill Saidpuradera Bassi Barwala Road Dera Bassi, Punjab, India
  • Industry
    Pharma, API Manufacturers

To see the full contact details of SCL Lifesciences Limited, buy the company report.

Comprehensive company report
SCL Lifesciences Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

SCL Lifesciences operates one associated brand: SCL Lifesciences. Each brand links to its own profile.

BrandDescriptionWebsite
Contract-based manufacturing services for active pharmaceutical ingredients are provided.sauravchemicals.com

Business activity

The main business activity of SCL Lifesciences is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of SCL Lifesciences Limited, buy the company report.

Financials of SCL Lifesciences Limited

FY 2026 filings available

SCL Lifesciences Limited reported revenue of ₹305.27 Cr (down 10% YoY) for FY 2026.

Revenue · FY 2026
₹305.27 Cr ▼ 10%
Net profit · FY 2026
₹58.4 Cr margin 19.1%
EBITDA · FY 2026
₹86.63 Cr margin 28.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 10%
3 years · compounded
▼ 2%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 15%
5 years · compounded
▲ 11%

Revenue fell 10% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹305.27 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹86.63 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹58.4 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin28.4%
Net Profit Margin19.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of SCL Lifesciences Limited, buy the company report.

Board of directors of SCL Lifesciences Limited

SCL Lifesciences has 9 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Udayan SenguptaWhole-Time Director04 Oct 200521 Years 1 MonthsCurrent
Nitish MukherjeeDirector20 Nov 20187 Years 11 MonthsCurrent
Sameer SinglaDirector14 Feb 20197 Years 9 MonthsCurrent
Naohiro YoshidaDirector25 Aug 20215 Years 2 MonthsCurrent
Parveen GoyalManaging Director01 Apr 201214 Years 7 MonthsCurrent
Vijay Dilbagh RaiDirector14 Feb 20179 Years 9 MonthsCurrent
Showing 6 of 9 current directors. View all directors

Peer comparison

SCL Lifesciences Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (API Manufacturers, Lifesciences), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
R.L.Fine Chem Private Limited₹360.48 Cr (FY 2025)6.0%Bangalore, Karnataka, India
Tirupati Lifesciences Private Limited₹350.76 Cr (FY 2025)12.0%Paonta Sahib, Himachal Pradesh, India
Haleos Labs Limited₹349.58 Cr (FY 2025)13.0%Hyderabad, Telangana, India
Valiant Laboratories Limited₹338.77 Cr (FY 2023)61.0%Mumbai, Maharashtra, India
Mangalam Drugs and Organics Limited₹318.73 Cr (FY 2025)-14.0%Mumbai, Maharashtra, India
Saraca Laboratories Limited₹310.45 Cr (FY 2025)11.0%Hyderabad, Telangana, India
SCL Lifesciences Limitedthis company₹305.27 Cr (FY 2026)₹58.4 Cr19.1%-10.0%862Punjab, India

To see the full peer comparison of SCL Lifesciences Limited, buy the company report.

Auditor

SCL Lifesciences Limited is audited by S.Tandon & Associates for the financial year 2026.

Auditor firmFinancial yearFirm registration number
S.Tandon & AssociatesFY 2026006388N

Shareholding

The shareholding of SCL Lifesciences Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2025FY 2024FY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of SCL Lifesciences Limited, buy the company report.

Charges & borrowings

Open charges
₹30.75 Cr
Satisfied charges
₹109.32 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹20.75 Cr
The Hongkong and Shanghai Banking Corporation Limited₹10.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
12 Jun 201410510845The Hongkong and Shanghai Banking Corporation Limited₹10 CrOpen
18 Feb 201310407458Hdfc Bank Limited₹20.75 CrOpen
30 Sep 2016100056779State Bank of India₹14 CrSatisfied
28 Oct 201410530435The Hongkong and Shanghai Banking Corporation Limited₹1.85 CrSatisfied
14 Aug 201410521874Hdfc Bank Limited₹5.75 CrSatisfied

To see the full charge records of SCL Lifesciences Limited, buy the company report.

Total charge records: 27 View all charges

Deals & funding

SCL Lifesciences Limited has 14 deals on record (10 secondary share transfers, 2 rights issues, 2 funding rounds), with disclosed funding of ₹15.2 Cr; the latest was in April 2024.

Total deals
14
Secondary share transfers
10
Rights issues
2
Funding rounds
2
Disclosed funding
₹15.2 Cr

Deals on record (5 of 14)

WhenDealAmountParties
Apr 2024Secondary share transferUndisclosedBuyer: 3 individuals
Seller: Parveen Goyal & Sons HUF
Jun 2020Secondary share transferUndisclosedBuyer: Goyal Family Trust
Seller: an individual
Aug 2019Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Aug 2016Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 2 individuals
Mar 2011Rights issue₹2.55 CrInvestors: Indian Voice Private Limited , 3 individuals

To see the full deal history of SCL Lifesciences Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

SCL Lifesciences Limited was last rated by Crisil on 25 Sep 2020.

Rating agencyRated onRating
Crisil25 Sep 2020

To see the full credit ratings and regulatory alerts of SCL Lifesciences Limited, buy the company report.

MSME payment delays

SCL Lifesciences Limited has 21 MSME Form 1 returns on record between 2019 and 2024, listing 61 overdue payments to 37 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 37)

SupplierAmount dueDue sinceReported on
an individual supplier
Shiva Scientific Glass Private Limited
Radix Electrosystems Pvt Ltd
Iee Elevators Private Limited
Sanco Infra Projects

To see the full MSME payment records of SCL Lifesciences Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

SCL Lifesciences Limited has a workforce of 862 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
862
Active EPFO establishments
1

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27862
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of SCL Lifesciences Limited, buy the company report.

GST

SCL Lifesciences has 15 GST registrations: 5 active and 10 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
15
Active
5
Cancelled / inactive
10
GSTINStateStatusRegistered on
03AACCS4745B1ZUPunjabActive01 Jul 2017
06AACCS4745B3ZMHaryanaActive02 Jul 2017
06AACCS4745B4ZLHaryanaActive28 Aug 2017
09AACCS4745B1ZIUttar PradeshActive30 Dec 2021

To see the full GST registrations and return filing status of SCL Lifesciences Limited, buy the company report.

Recent activity

SCL Lifesciences Limited has 27 board changes on record since 2004: 12 appointments and 15 cessations. The latest: Anil Chaudhry was appointed as Director on 16 Jul 2025.

AGM
Scl Lifesciences Limited last Annual general meeting of members was held on 15 Jun 2026 as per latest MCA records.
Filing
Scl Lifesciences Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Chandigarh.
Charges
A charge registered on 28 Oct 2014 via Charge ID 10530435 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 10 Oct 2025.
Appointed
Anil Chaudhry was appointed as Director.
Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited of Rs. 10.00 Cr registered on 12 Jun 2014 with Charge ID 10510845 was modified on 15 Apr 2025.
Appointed
Shweta Mehta was appointed as Director.
Charges
A charge registered on 14 Aug 2014 via Charge ID 10521874 with Hdfc Bank Limited was fully satisfied on 30 Jun 2023.
Charges
A charge with Hdfc Bank Limited of Rs. 20.75 Cr registered on 18 Feb 2013 with Charge ID 10407458 was modified on 26 May 2023.
Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited of Rs. 1.85 Cr registered on 28 Oct 2014 with Charge ID 10530435 was modified on 28 Mar 2023.
Appointed
Kamal Kant Gambhir was appointed as CFO.
Ceased
Naohiro Yoshida ceased to be Additional Director.
Ceased
Kamal Kant Gambhir ceased to be Cfo(Kmp).

80 earlier events are in the company report.

Frequently asked questions

SCL Lifesciences is an active public limited company based in Punjab, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 20 December 1993 (33+ years old) and is registered under CIN U24112PB1993PLC014017.

SCL Lifesciences has 9 current directors:

The latest financial statements of SCL Lifesciences on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 15 June 2026. Year-wise statements from 2015 are in the company report.

The GSTIN of SCL Lifesciences is 03AACCS4745B1ZU, registered in Punjab. The company has 15 GST registrations in all, of which 5 are active and 10 are cancelled or inactive. Other active GSTINs include 06AACCS4745B3ZM (Haryana), 06AACCS4745B4ZL (Haryana), 09AACCS4745B1ZI (Uttar Pradesh).

The CIN (Corporate Identification Number) of SCL Lifesciences is U24112PB1993PLC014017. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

SCL Lifesciences has 2 court cases on record: 1 filed by the company and 1 filed against it. 1 is pending.

SCL Lifesciences was incorporated on 20 December 1993, making it 33+ years old. It is registered with the Registrar of Companies, Chandigarh.

SCL Lifesciences has 14 deals on record (10 secondary share transfers, 2 rights issues, 2 funding rounds), with disclosed funding of ₹15.2 Cr; the latest was in April 2024.

The peers of SCL Lifesciences by revenue are R.L.Fine Chem Private Limited, Tirupati Lifesciences Private Limited, Haleos Labs Limited, Valiant Laboratories Limited, Mangalam Drugs and Organics Limited and 1 more, all in the Pharma industry (API Manufacturers, Lifesciences), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).

Anil Chaudhry was appointed as Director on 16 Jul 2025. Shweta Mehta was appointed as Director on 28 Aug 2023. Kamal Kant Gambhir was appointed as CFO on 01 Aug 2022. SCL Lifesciences has 27 board changes on record in total.

Yes, SCL Lifesciences is registered as a medium enterprise under Udyam registration (number: UDYAM-HR-13-0000327).

SCL Lifesciences has 21 MSME Form 1 returns on record between 2019 and 2024, listing 61 overdue payments to 37 micro and small suppliers. The latest return was filed on 20 Apr 2024.